Cargando…

Differences in the public medical insurance systems for inflammatory bowel disease treatment in Asian countries

BACKGROUND/AIMS: The cost of caring for patients with inflammatory bowel disease (IBD) is high. Without government support, the cost burden will unavoidably rest on the patients and their family. However, the government providing full support will place a large financial burden on the health-care sy...

Descripción completa

Detalles Bibliográficos
Autor principal:	Wei, Shu Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Association for the Study of Intestinal Diseases 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945525/ https://www.ncbi.nlm.nih.gov/pubmed/27433143 http://dx.doi.org/10.5217/ir.2016.14.3.218

Ejemplares similares

How have treatment patterns for patients with inflammatory bowel disease changed in Asian countries?
por: Park, Jihye
Publicado: (2023)

The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries
por: Aniwan, Satimai, et al.
Publicado: (2022)

Results of the first survey for the current status of inflammatory bowel disease management in Asian countries
por: Kim, Ji Won
Publicado: (2016)

Should Asian inflammatory bowel disease patients need routine thromboprophylaxis?
por: Weng, Meng-Tzu, et al.
Publicado: (2018)

Diagnosis, management, and prevention of infectious complications in inflammatory bowel disease: variations among Asian countries
por: Baek, Ji Eun, et al.
Publicado: (2023)

Inflammatory bowel disease and the South Asian diaspora
por: Farrukh, Affifa, et al.
Publicado: (2019)

Public versus Private Drug Insurance and Outcomes of Patients Requiring Biologic Therapies for Inflammatory Bowel Disease
por: Rumman, Amir, et al.
Publicado: (2017)

Differences in healthcare expenditures for inflammatory bowel disease by insurance status, income, and clinical care setting
por: Park, Michelle D., et al.
Publicado: (2014)

Review of evolution of the public long-term care insurance (LTCI) system in different countries: influence and challenge
por: Chen, Linhong, et al.
Publicado: (2020)

Very early onset inflammatory bowel disease in a South Asian country where inflammatory bowel disease is emerging: a distinct clinical phenotype from later onset disease
por: Banerjee, Rupa, et al.
Publicado: (2021)

Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients
por: Park, Sung Chul, et al.
Publicado: (2019)

Diet and inflammatory bowel disease: The Asian Working Group guidelines
por: Sood, Ajit, et al.
Publicado: (2019)

Pediatric inflammatory bowel disease: Is it really uncommon in Asian children?
por: Poddar, Ujjal, et al.
Publicado: (2020)

Pediatric to adult inflammatory bowel disease transition: the Asian experience
por: Tan, Bernice, et al.
Publicado: (2020)

Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
por: Banerjee, Rupa, et al.
Publicado: (2020)

Variable outcome in infantile-onset inflammatory bowel disease in an Asian cohort
por: Lee, Way Seah, et al.
Publicado: (2016)

Genetic associations of inflammatory bowel disease in a South Asian population
por: Niriella, Madunil Anuk, et al.
Publicado: (2018)

Clinical and lifestyle patterns in Asian children with inflammatory bowel disease in the U.S.
por: Zong, Wenjing, et al.
Publicado: (2023)

The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis
por: Imawana, Rabbiaatul Addawiyah, et al.
Publicado: (2020)

Influences of Public Medical Insurance System on Labor Health Status and Supply
por: Bai, Bing, et al.
Publicado: (2021)

Analysis of Safety, Medical Resource Utilization, and Treatment Costs by Drug Class for Management of Inflammatory Bowel Disease in the United States Based on Insurance Claims Data
por: Long, Gráinne H., et al.
Publicado: (2019)

Vaccination in patients with inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
por: Park, Su Bum, et al.
Publicado: (2023)

Variations in the medical treatment of inflammatory bowel disease among gastroenterologists
por: Singh, Shailendra, et al.
Publicado: (2018)

Medication adherence in inflammatory bowel disease
por: Chan, Webber, et al.
Publicado: (2017)

Medical insurance for treatment of periodontal disease
por: Thomas, Biju
Publicado: (2015)

Predicting outcomes to optimize disease management in inflammatory bowel disease in Japan: their differences and similarities to Western countries
por: Kobayashi, Taku, et al.
Publicado: (2018)

Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
por: Fujiya, Mikihiro, et al.
Publicado: (2022)

Treatment of Inflammatory Bowel Disease: A Comprehensive Review
por: Cai, Zhaobei, et al.
Publicado: (2021)

Economic Burden of Heart Failure in Asian Countries with Different Healthcare Systems
por: Yingchoncharoen, Teerapat, et al.
Publicado: (2021)

The Positive Influences of Increasing Age at Diagnosis of Inflammatory Bowel Disease on Disease Prognostication in Asian Perspective
por: Ali, Raja Affendi Raja
Publicado: (2015)

Thrombophilia in East Asian countries: are there any genetic differences in these countries?
por: Miyata, Toshiyuki, et al.
Publicado: (2016)

Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
por: Song, Eun Mi, et al.
Publicado: (2023)

Prognostic influence of Korean public medical insurance system on breast cancer patients
por: Hwang, Ki-Tae, et al.
Publicado: (2019)

Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
por: Yao, Ling-Ya, et al.
Publicado: (2022)

Epidemiological characteristics of Asian children with inflammatory bowel disease at diagnosis: Insights from an Asian-Pacific multi-centre registry network
por: Huang, James Guoxian, et al.
Publicado: (2022)

Patient and Public Involvement in Research: Lessons for Inflammatory Bowel Disease
por: Honap, Sailish, et al.
Publicado: (2023)

The Role of the Lymphatic System in the Pathogenesis and Treatment of Inflammatory Bowel Disease
por: Nikolakis, Dimitrios, et al.
Publicado: (2022)

Comprehension of Quality Care Indicators: Differences Among Privately Insured, Publicly Insured, and Uninsured
por: Jewett, Jacquelyn J., et al.
Publicado: (1996)

3334 Insurance Generosity and Inflammatory Bowel Disease: Does Higher Patient Cost-Sharing Result in Suboptimal Medication Habits and Inferior Clinical Outcomes?
por: Sceats, Lindsay Anne, et al.
Publicado: (2019)

Risk of venous thromboembolism in Asian patients with inflammatory bowel disease: a nationwide cohort study
por: Heo, Chan Mi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s9buuou3s19c5srp01tn5s6e7e